{
    "2020-07-24": [
        [
            {
                "time": "",
                "original_text": "医药生物行业：20Q2主动公募医药持仓维持大幅超配状态 重仓集中度有所下降",
                "features": {
                    "keywords": [
                        "医药生物",
                        "20Q2",
                        "主动公募",
                        "持仓",
                        "超配",
                        "重仓集中度"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "乐普心贴ER1，记录热爱运动的你每一次心跳",
                "features": {
                    "keywords": [
                        "乐普心贴",
                        "ER1",
                        "运动",
                        "心跳"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗器械"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "挪威评估17种新冠抗体试剂 5个中国产品被判“不可接受”",
                "features": {
                    "keywords": [
                        "挪威",
                        "新冠抗体试剂",
                        "中国产品",
                        "不可接受"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医疗健康行业基金2Q分析：2季度仓位同比和环比上升 风险偏好依然较高",
                "features": {
                    "keywords": [
                        "医疗健康",
                        "基金",
                        "2Q",
                        "仓位",
                        "风险偏好"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "米内网发布2019年度中国医药工业百强系列榜单",
                "features": {
                    "keywords": [
                        "米内网",
                        "2019",
                        "医药工业",
                        "百强榜单"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药工业"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}